{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360292618508564992.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1212/01.wnl.0000187129.66353.13"}},{"identifier":{"@type":"URI","@value":"https://www.neurology.org/doi/pdfdirect/10.1212/01.wnl.0000187129.66353.13"}}],"dc:title":[{"@value":"Serum antibodies in epilepsy and seizure-associated disorders"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380292618508564993","@type":"Researcher","foaf:name":[{"@value":"K. McKnight"}],"jpcoar:affiliationName":[{"@value":"From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford (Drs. McKnight, Vincent, and Lang and Y. Jiang); Department of Clinical Neurology, Radcliffe Infirmary, Oxford (Drs. Hart and Palace and A. Cavey); National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom (Dr. Wroe); and Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty..."}]},{"@id":"https://cir.nii.ac.jp/crid/1380292618508564994","@type":"Researcher","foaf:name":[{"@value":"Y. Jiang"}],"jpcoar:affiliationName":[{"@value":"From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford (Drs. McKnight, Vincent, and Lang and Y. Jiang); Department of Clinical Neurology, Radcliffe Infirmary, Oxford (Drs. Hart and Palace and A. Cavey); National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom (Dr. Wroe); and Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty..."}]},{"@id":"https://cir.nii.ac.jp/crid/1380292618508564869","@type":"Researcher","foaf:name":[{"@value":"Y. Hart"}],"jpcoar:affiliationName":[{"@value":"From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford (Drs. McKnight, Vincent, and Lang and Y. Jiang); Department of Clinical Neurology, Radcliffe Infirmary, Oxford (Drs. Hart and Palace and A. Cavey); National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom (Dr. Wroe); and Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty..."}]},{"@id":"https://cir.nii.ac.jp/crid/1380292618508564864","@type":"Researcher","foaf:name":[{"@value":"A. Cavey"}],"jpcoar:affiliationName":[{"@value":"From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford (Drs. McKnight, Vincent, and Lang and Y. Jiang); Department of Clinical Neurology, Radcliffe Infirmary, Oxford (Drs. Hart and Palace and A. Cavey); National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom (Dr. Wroe); and Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty..."}]},{"@id":"https://cir.nii.ac.jp/crid/1380292618508564868","@type":"Researcher","foaf:name":[{"@value":"S. Wroe"}],"jpcoar:affiliationName":[{"@value":"From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford (Drs. McKnight, Vincent, and Lang and Y. Jiang); Department of Clinical Neurology, Radcliffe Infirmary, Oxford (Drs. Hart and Palace and A. Cavey); National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom (Dr. Wroe); and Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty..."}]},{"@id":"https://cir.nii.ac.jp/crid/1380292618508564865","@type":"Researcher","foaf:name":[{"@value":"M. Blank"}],"jpcoar:affiliationName":[{"@value":"From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford (Drs. McKnight, Vincent, and Lang and Y. Jiang); Department of Clinical Neurology, Radcliffe Infirmary, Oxford (Drs. Hart and Palace and A. Cavey); National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom (Dr. Wroe); and Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty..."}]},{"@id":"https://cir.nii.ac.jp/crid/1380292618508564870","@type":"Researcher","foaf:name":[{"@value":"Y. Shoenfeld"}],"jpcoar:affiliationName":[{"@value":"From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford (Drs. McKnight, Vincent, and Lang and Y. Jiang); Department of Clinical Neurology, Radcliffe Infirmary, Oxford (Drs. Hart and Palace and A. Cavey); National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom (Dr. Wroe); and Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty..."}]},{"@id":"https://cir.nii.ac.jp/crid/1380292618508564867","@type":"Researcher","foaf:name":[{"@value":"A. Vincent"}],"jpcoar:affiliationName":[{"@value":"From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford (Drs. McKnight, Vincent, and Lang and Y. Jiang); Department of Clinical Neurology, Radcliffe Infirmary, Oxford (Drs. Hart and Palace and A. Cavey); National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom (Dr. Wroe); and Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty..."}]},{"@id":"https://cir.nii.ac.jp/crid/1380292618508564866","@type":"Researcher","foaf:name":[{"@value":"J. Palace"}],"jpcoar:affiliationName":[{"@value":"From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford (Drs. McKnight, Vincent, and Lang and Y. Jiang); Department of Clinical Neurology, Radcliffe Infirmary, Oxford (Drs. Hart and Palace and A. Cavey); National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom (Dr. Wroe); and Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty..."}]},{"@id":"https://cir.nii.ac.jp/crid/1380292618508564992","@type":"Researcher","foaf:name":[{"@value":"B. Lang"}],"jpcoar:affiliationName":[{"@value":"From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford (Drs. McKnight, Vincent, and Lang and Y. Jiang); Department of Clinical Neurology, Radcliffe Infirmary, Oxford (Drs. Hart and Palace and A. Cavey); National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom (Dr. Wroe); and Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty..."}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00283878"},{"@type":"EISSN","@value":"1526632X"},{"@type":"PISSN","@value":"http://id.crossref.org/issn/00283878"}],"prism:publicationName":[{"@value":"Neurology"}],"dc:publisher":[{"@value":"Ovid Technologies (Wolters Kluwer Health)"}],"prism:publicationDate":"2005-12-13","prism:volume":"65","prism:number":"11","prism:startingPage":"1730","prism:endingPage":"1736"},"reviewed":"false","url":[{"@id":"https://www.neurology.org/doi/pdfdirect/10.1212/01.wnl.0000187129.66353.13"}],"createdAt":"2006-07-12","modifiedAt":"2024-03-28","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360285707079754624","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A case of autoimmune epilepsy associated with anti-leucine-rich glioma inactivated subunit 1 antibodies manifesting electrical shock-like sensations and transparent sadness"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205034742912","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A case of immune-mediated encephalopathy showing refractory epilepsy and extensive brain MRI lesions associated with anti-glutamic acid decarboxylase antibody"},{"@language":"ja","@value":"頭部ＭＲＩにて広汎な病変をみとめ，抗ＧＡＤ抗体の関連が示唆された免疫介在性脳症の１例"},{"@value":"症例報告 頭部MRIにて広汎な病変をみとめ,抗GAD抗体の関連が示唆された免疫介在性脳症の1例"},{"@language":"ja-Kana","@value":"ショウレイ ホウコク トウブ MRI ニテ コウハン ナ ビョウヘン オ ミトメ コウGAD コウタイ ノ カンレン ガ シサ サレタ メンエキ カイザイセイ ノウショウ ノ 1レイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205035000064","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"多系統萎縮症との鑑別を要した多腺性自己免疫症候群関連パーキンソン症候群の1例"},{"@language":"en","@value":"A case of autoimmune polyglandular syndrome -related Parkinsonian syndrome that required differentiation from multiple system atrophy"},{"@value":"症例報告 多系統萎縮症との鑑別を要した多腺性自己免疫症候群関連パーキンソン症候群の1例"},{"@language":"ja-Kana","@value":"ショウレイ ホウコク タケイトウ イシュクショウ ト ノ カンベツ オ ヨウシタ タセンセイ ジコ メンエキ ショウコウグン カンレン パーキンソン ショウコウグン ノ 1レイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205083337728","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Limbic Encephalitis Associated with Anti-Voltage-Gated Potassium Channel Complex Antibodies as a Cause of Adult-Onset Mesial Temporal Lobe Epilepsy"},{"@language":"ja","@value":"抗Voltage-Gated Potassium Channel複合体抗体関連辺縁系脳炎の関与が考えられた成人発症内側側頭葉てんかんの1例"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001288121218816","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"抗glutamic acid decarboxylase抗体高値の焦点性てんかん4例の臨床的検討"},{"@language":"en","@value":"Clinical Characteristics of Four Cases of Focal Epilepsy with Elevated Anti-glutamic Acid Decarboxylase Antibodies"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679829661184","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A Case of Thymoma with Anti-GAD Antibody Positive Myasthenia Gravis"},{"@language":"ja","@value":"抗GAD抗体陽性重症筋無力症合併胸腺腫の1例"},{"@value":"症例 抗GAD抗体陽性重症筋無力症合併胸腺腫の1例"},{"@language":"ja-Kana","@value":"ショウレイ コウGAD コウタイ ヨウセイ ジュウショウ キンムリョクショウ ガッペイ キョウセン シュ ノ 1レイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390570707164863616","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A case of anti-glutamic acid decarboxylase(GAD) antibody-associated temporal lobe epilepsy presenting with suspected ictal bradycardia syndrome"},{"@language":"ja","@value":"発作性徐脈症候群の関与を疑った抗glutamic acid decarboxylase（GAD）抗体関連の難治性てんかんの一例"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1212/01.wnl.0000187129.66353.13"},{"@type":"CROSSREF","@value":"10.3805/jjes.36.637_references_DOI_PyzBdvQZPj7Wrm0p8MHHZV7Dikb"},{"@type":"CROSSREF","@value":"10.7888/juoeh.36.129_references_DOI_PyzBdvQZPj7Wrm0p8MHHZV7Dikb"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.50.704_references_DOI_PyzBdvQZPj7Wrm0p8MHHZV7Dikb"},{"@type":"CROSSREF","@value":"10.3919/jjsa.74.2101_references_DOI_PyzBdvQZPj7Wrm0p8MHHZV7Dikb"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.50.92_references_DOI_PyzBdvQZPj7Wrm0p8MHHZV7Dikb"},{"@type":"CROSSREF","@value":"10.3918/jsicm.28_445_references_DOI_PyzBdvQZPj7Wrm0p8MHHZV7Dikb"},{"@type":"CROSSREF","@value":"10.1016/j.ebcr.2015.08.004_references_DOI_PyzBdvQZPj7Wrm0p8MHHZV7Dikb"}]}